- Home
- SAVA vs RC Comparison
SAVA vs RC Comparison
Compare SAVA & RC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SAVA
- RC
- Stock Information
- Founded
- SAVA 1998
- RC 2007
- Country
- SAVA United States
- RC United States
- Employees
- SAVA N/A
- RC N/A
- Industry
- SAVA Biotechnology: Pharmaceutical Preparations
- RC Real Estate Investment Trusts
- Sector
- SAVA Health Care
- RC Real Estate
- Exchange
- SAVA Nasdaq
- RC Nasdaq
- Market Cap
- SAVA 1.3B
- RC 1.3B
- IPO Year
- SAVA N/A
- RC N/A
- Fundamental
- Price
- SAVA $27.08
- RC $7.32
- Analyst Decision
- SAVA Buy
- RC Hold
- Analyst Count
- SAVA 3
- RC 9
- Target Price
- SAVA $107.00
- RC $32.88
- AVG Volume (30 Days)
- SAVA 1.9M
- RC 2.2M
- Earning Date
- SAVA 11-05-2024
- RC 11-05-2024
- Dividend Yield
- SAVA N/A
- RC 13.67%
- EPS Growth
- SAVA N/A
- RC N/A
- EPS
- SAVA N/A
- RC N/A
- Revenue
- SAVA N/A
- RC $226,109,000.00
- Revenue This Year
- SAVA N/A
- RC N/A
- Revenue Next Year
- SAVA N/A
- RC $14.03
- P/E Ratio
- SAVA N/A
- RC N/A
- Revenue Growth
- SAVA N/A
- RC N/A
- 52 Week Low
- SAVA $8.79
- RC $7.23
- 52 Week High
- SAVA $42.20
- RC $11.67
- Technical
- Relative Strength Index (RSI)
- SAVA 46.80
- RC 35.02
- Support Level
- SAVA $26.10
- RC $7.31
- Resistance Level
- SAVA $31.65
- RC $7.96
- Average True Range (ATR)
- SAVA 2.55
- RC 0.19
- MACD
- SAVA -0.50
- RC -0.03
- Stochastic Oscillator
- SAVA 15.08
- RC 10.95
About SAVA Cassava Sciences Inc.
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease; and investigational diagnostic product candidate is called SavaDx, and it is a novel way to detect the presence of Alzheimer's disease from a small sample of blood, possibly years before the overt appearance of clinical symptoms. It is currently conducting two randomized placebo-controlled Phase 3 clinical trials of oral simufilam in patients with Alzheimer's disease dementia.
About RC Ready Capital Corproation
Ready Capital Corp is a real estate finance company. It acquires, manages, originates, and finances small-balance commercial loans to purchase small multi-family, office, retail, mixed-use, or warehouse properties. The company's segments consist of LMM Commercial Real Estate and Small Business Lending. It generates the majority of its revenue from LMM Commercial Real Estate.